The Northbridge
point of view.
Research, case studies and partner commentary. Published when we have something unfashionable to say — never on a content calendar.
The next price reset: living with structurally higher rates
Why the 2024–2026 rate environment has quietly rewritten the rulebook on B2B price architecture — and what the leading industrial groups are doing about it.
- PaperJun 2026Pricing
The next price reset: living with structurally higher rates
Why the 2024–2026 rate environment has quietly rewritten the rulebook on B2B price architecture — and what the leading industrial groups are doing about it.
By Christian Halberg · 14 min readRead → - Case StudyMay 2026SaaS
From 14 SKUs to 3: a $260M ARR re-packaging
How a category-leading horizontal SaaS replaced a tangled freemium catalogue with three editions — and lifted NRR from 104% to 131% in seven quarters.
By Priya N. Iyer · 9 min readRead → - LetterApr 2026Firm
A letter from the Managing Partner: the next decade
On the firm's 35th anniversary, our managing partner sets out the three commitments that will define Northbridge through 2035.
By Mia Aldenburg · 6 min readRead → - PaperApr 2026AI
AI in the deal-cycle: where the margin actually shows up
Six places where generative AI has measurably moved sales-cycle economics in 2025–2026 engagements — and three where it hasn't.
By Priya N. Iyer · 11 min readRead → - Case StudyMar 2026Industrial
+14 pts of margin in 18 months at a €3B European group
A line-by-line rebuild of the price architecture across 12 product lines, 4 channels and 9 markets — without losing a single strategic account.
By Rohan Vasquez · 8 min readRead → - InterviewFeb 2026Growth
Mia Aldenburg on building a 24-month roadmap your board can underwrite
A conversation about why most growth plans collapse in quarter two — and the discipline that makes a few of them stick.
By Mia Aldenburg · 7 min readRead → - PaperJan 2026Healthcare
Launch economics in a fragmented payer landscape
A practical framework for sequencing access, price and channel decisions across the first 1,000 days of a medtech launch.
By Sara Kazem · 12 min readRead →